Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas P Kilpeläinen

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
European Urology Focus|October 24, 2021
Evidence-based Urology: Subgroup Analysis in Randomized Controlled TrialsTuomas P Kilpeläinen, Kari A O Tikkinen, Gordon H Guyatt, et al.
American Journal of Epidemiology|October 26, 2016
Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate CancerTuomas P Kilpeläinen, Kirsi Talala, Jani Raitanen, et al.
European Urology Open Science|November 10, 2022
Risk of Complications After Hydrocele Surgery: A Retrospective Multicenter Study in Helsinki Metropolitan AreaLauri Mäki-Lohiluoma, Tuomas P Kilpeläinen, Petrus Järvinen, et al.
Scandinavian Journal of Urology|January 22, 2019
Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy eraSara V Tornberg, Harri Visapää, Tuomas P Kilpeläinen, et al.
International Journal of Cancer|May 18, 2010
Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screeningTuomas P Kilpeläinen, Anssi Auvinen, Liisa Määttänen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2020
Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate CancerTuomas P Kilpeläinen, Kirsi Talala, Kimmo Taari, et al.
European Urology Focus|October 25, 2023
Pros and Cons of Noninferiority TrialsSandra Ofori, Sara V Tornberg, Tuomas P Kilpeläinen, et al.
International Journal of Cancer|January 18, 2019
Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancerAntti Lindberg, Kirsi Talala, Paula Kujala, et al.
Scandinavian Journal of Urology|August 5, 2020
Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinomaSara V Tornberg, Harry Nisen, Petrus Järvinen, et al.
Plos One|December 28, 2017
Repeat multiparametric MRI in prostate cancer patients on active surveillanceJuho T Eineluoto, Petrus Järvinen, Anu Kenttämies, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
European Urology Focus|October 24, 2021
Evidence-based Urology: Subgroup Analysis in Randomized Controlled TrialsTuomas P Kilpeläinen, Kari A O Tikkinen, Gordon H Guyatt, et al.
American Journal of Epidemiology|October 26, 2016
Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate CancerTuomas P Kilpeläinen, Kirsi Talala, Jani Raitanen, et al.
European Urology Open Science|November 10, 2022
Risk of Complications After Hydrocele Surgery: A Retrospective Multicenter Study in Helsinki Metropolitan AreaLauri Mäki-Lohiluoma, Tuomas P Kilpeläinen, Petrus Järvinen, et al.
Scandinavian Journal of Urology|January 22, 2019
Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy eraSara V Tornberg, Harri Visapää, Tuomas P Kilpeläinen, et al.
International Journal of Cancer|May 18, 2010
Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screeningTuomas P Kilpeläinen, Anssi Auvinen, Liisa Määttänen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2020
Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for Prostate CancerTuomas P Kilpeläinen, Kirsi Talala, Kimmo Taari, et al.
European Urology Focus|October 25, 2023
Pros and Cons of Noninferiority TrialsSandra Ofori, Sara V Tornberg, Tuomas P Kilpeläinen, et al.
International Journal of Cancer|January 18, 2019
Bias-corrected estimates of effects of PSA screening decisions on the risk of prostate cancer diagnosis and death: Analysis of the Finnish randomized study of screening for prostate cancerAntti Lindberg, Kirsi Talala, Paula Kujala, et al.
Scandinavian Journal of Urology|August 5, 2020
Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinomaSara V Tornberg, Harry Nisen, Petrus Järvinen, et al.
Plos One|December 28, 2017
Repeat multiparametric MRI in prostate cancer patients on active surveillanceJuho T Eineluoto, Petrus Järvinen, Anu Kenttämies, et al.
Pageof 4